CompletedPhase 2NCT00481013

Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy

Studying Autosomal dominant adult-onset proximal spinal muscular atrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Utah
Principal Investigator
John T Kissel, PT
Ohio State University
Intervention
Valproic Acid (VPA)(drug)
Enrollment
33 enrolled
Eligibility
18-60 years · All sexes
Timeline
20072010

Study locations (1)

Collaborators

Families of Spinal Muscular Atrophy · Abbott

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00481013 on ClinicalTrials.gov

Other trials for Autosomal dominant adult-onset proximal spinal muscular atrophy

Additional recruiting or active studies for the same condition.

See all trials for Autosomal dominant adult-onset proximal spinal muscular atrophy

← Back to all trials